McKesson Corp (MCK) has received a high rating from Validea’s Multi-Factor Investor model, based on the strategy of Pim van Vliet. This strategy looks for low volatility stocks with strong momentum and high net payout yields. MCK is a large-cap growth stock in the Major Drugs industry, with a rating of 100% based on underlying fundamentals and valuation. The stock meets the criteria for market cap and standard deviation, with a neutral rating for momentum and net payout yield. Pim van Vliet’s research shows that low volatility stocks can outperform high volatility ones with less risk.

Read more at Nasdaq: MCK Quantitative Stock Analysis | Nasdaq